Welcome to the Cancer Diagnosis Program
The Cancer Diagnosis Program (CDP) strives to improve the diagnosis and assessment of cancer by effectively moving new scientific knowledge into clinical practice. This national program stimulates, co-ordinates and funds resources and research on diagnostics and improved technologies to better characterize cancers to guide the choice of treatment as well as to evaluate the response to treatment.
Clinical Assay Development Program (CADP)
The CADP is designed to identify promising tests, assess the needs for further development, and provide services to facilitate optimization of analytical performance and to establish clinical validity so that the clinical utility of the assay can be evaluated in well-designed clinical studies. More…
Strategic Partnering to Evaluate Cancer Signatures (SPECS)
The goals of the SPECS programs are: To translate molecular signatures/profiles derived from comprehensive molecular analysis of tumors to improved patient management and ultimately improved patient outcomes; To establish strategic partnerships that bring together the interdisciplinary teams needed to evaluate the potential clinical utility of molecular signatures. More…
